{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:02:36Z","timestamp":1773280956090,"version":"3.50.1"},"reference-count":43,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1188\/05.cjon.584-592","type":"journal-article","created":{"date-parts":[[2006,2,20]],"date-time":"2006-02-20T08:32:51Z","timestamp":1140424371000},"page":"584-592","source":"Crossref","is-referenced-by-count":54,"title":["Current Trends in Managing Oral Mucositis"],"prefix":"10.1188","volume":"9","author":[{"given":"Margaret M.","family":"Cawley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Benson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,2,8]]},"reference":[{"key":"E00001","unstructured":"Amgen Inc. (2004). Kepivance\u2122 (palifermin) prescribing information. Thousand Oaks, CA: Author."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Avritscher, E.B., Cooksley, C.D., & Elting, L.S. (2004). Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Seminars in Oncology Nursing<\/i>, 20<\/i>, 3-10.","DOI":"10.1053\/j.soncn.2003.10.002"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Barasch, A., & Peterson, D.E. (2003). Risk factors for ulcerative mucositis in cancer patients: Unanswered questions. Oral Oncology<\/i>, 39<\/i>, 91-100.","DOI":"10.1016\/S1368-8375(02)00033-7"},{"key":"E00004","unstructured":"Beck, S. (1979). Impact of a systemic oral care protocol on stomatitis after chemotherapy. Cancer Nursing<\/i>, 2<\/i>, 185-199."},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Bellm, L.A., Cunningham, G., Durnell, L., Eilers, J., Epstein, J.B., Fleming, T., et al. (2002). Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: Oral mucositis patient provider advisory board. Cancer Investigation<\/i>, 20<\/i>, 793-800.","DOI":"10.1081\/CNV-120002497"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Brizel, D.M., Wasserman, T.H., Henke, M., Strnad, V., Rudat, V., Monnier, A., et al. (2000). Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. Journal of Clinical Oncology<\/i>, 18<\/i>, 3339-3345.","DOI":"10.1200\/JCO.2000.18.19.3339"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Brown, C.G., & Wingard, J. (2004). Clinical consequences of oral mucositis. Seminars in Oncology Nursing<\/i>, 20<\/i>, 16-21.","DOI":"10.1053\/j.soncn.2003.10.004"},{"key":"E00008","unstructured":"Buchsel, P.C. (2003). Gelclair oral gel. Clinical Journal of Oncology Nursing<\/i>, 7<\/i>, 109-110."},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Cella, D., Pulliam, J., Fuchs, H., Miller, C., Hurd, D., Wingard, J.R., et al. (2003). Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy. Cancer<\/i>, 98<\/i>, 406-412.","DOI":"10.1002\/cncr.11505"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Dodd, M.J., Dibble, S.L., Miaskowski, C., MacPhail, L., Greenspan, D., Paul, S.M., et al. (2000). Randomized clinical trials of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics<\/i>, 90<\/i>, 39-47.","DOI":"10.1067\/moe.2000.105713"},{"key":"E00011","unstructured":"Eilers, J., Berger, A.M., & Peterson, M.C. (1988). Development, testing, and application of the oral assessment guide. Oncology Nursing Forum<\/i>, 15<\/i>, 325-330."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Elting, L.S., Cooksley, C., Chambers, M., Cantor, S.B., Manzullo, E., & Rubenstein, E.B. (2003). The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer<\/i>, 98<\/i>, 1531-1539.","DOI":"10.1002\/cncr.11671"},{"key":"E00013","unstructured":"Epstein, J.B., & Schubert, M.M. (2003). Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology<\/i>, 17<\/i>, 1767-1782."},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Innocenti, M., Moscatelli, G., & Lopez, S. (2002). Efficacy of Gelclair in reducing pain in palliative care patients with oral lesions: Preliminary findings from an open pilot study. Journal of Pain and Symptom Management<\/i>, 24<\/i>, 456-457.","DOI":"10.1016\/S0885-3924(02)00524-9"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Khan, S.A., & Wingard, J.R. (2001). Infection and mucosal injury in cancer treatment. Journal of the National Cancer Institute Monographs<\/i>, 29<\/i>, 31-36.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003437"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"McGuire, D.B., Peterson, D.E., Muller, S., Owen, D.C., Slemmons, M.F., & Schubert, M.M. (2002). The 20 item oral mucositis index: Reliability and validity in bone marrow and stem cell transplant patients. Cancer Investigation<\/i>, 20<\/i>, 893-903.","DOI":"10.1081\/CNV-120005902"},{"key":"E00017","unstructured":"MedImmune Oncology, Inc. (2003). Ethyol\u00ae (amifostine) prescribing information. Gaithersburg, MD: Author."},{"key":"E00018","unstructured":"National Cancer Institute. (2003). Cancer therapy evaluation program. Common terminology criteria for adverse events, version 3.0. Retrieved August 22, 2005, from http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf<\/a>"},{"key":"E00019","unstructured":"National Cancer Institute. (2005). Oral complications of chemotherapy and head\/neck radiation (PDQ\u00ae). Retrieved August 22, 2005, from http:\/\/www.nci.nih.gov\/cancertopics\/pdq\/supportivecare\/oralcomplications\/healthprofessional<\/a>"},{"key":"E00020","unstructured":"OSI Oncology. (2003). Gelclair\u00ae bioadherent oral gel [Prescribing information]. Melville, NY: OSI Pharmaceuticals."},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Peterson, D.E., Beck, S.L., & Keefe, D.M. (2004). Novel therapies. Seminars in Oncology Nursing<\/i>, 20<\/i>, 53-58.","DOI":"10.1053\/j.soncn.2003.10.009"},{"key":"E00022","unstructured":"Peterson, D.E., & Petit, R.G. (2003). Phase III study: AES-14 in chemotherapy patients at risk for mucositis [Abstract 2917]. Proceedings of the American Society of Clinical Oncology<\/i>, 22<\/i>, 725."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Peterson, D.E., & Petit, R.G. (2004). Phase III study: AES-14 in patients at risk for mucositis secondary to anthracycline-based chemotherapy [Abstract 8008]. Journal of Clinical Oncology<\/i>, 22<\/i>(14, Suppl.), 2917.","DOI":"10.1200\/jco.2004.22.14_suppl.8008"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Pourreau-Schneider, N., Soudry, M., Franquin, J.C., Zattara, H., Martin, P.M., Ciais, G., et al. (1992). Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: A preliminary report. Journal of the National Cancer Institute<\/i>, 84<\/i>, 358-359.","DOI":"10.1093\/jnci\/84.5.358"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Raber-Durlacher, J.E. (1999). Current practices for management of oral mucositis in cancer patients. Supportive Care in Cancer<\/i>, 7<\/i>, 71-74.","DOI":"10.1007\/s005200050229"},{"key":"E00026","unstructured":"Rieger, P.T. (Ed.). (2001). Biotherapy: A comprehensive overview<\/i> (2nd ed.). Sudbury, MA: Jones and Bartlett."},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Sandoval, R.L., Koga, D.H., Buloto, L.S., Suzuki, R., & Dib, L.L. (2003). Management of chemo- and radiotherapy induced mucositis with low-energy laser: Initial results of A.C. Carmargo Hospital. Journal of Applied Oral Science<\/i>, 11<\/i>, 337-341.","DOI":"10.1590\/S1678-77572003000400012"},{"key":"E00028","unstructured":"Schubert, M.M. (1993). Measurement of oral tissue damage and mucositis pain. In C.R. Chapman & K. Foley (Eds.), Current and emerging issues in research on cancer pain<\/i> (chap. 15). Retrieved May 7, 2004, from http:\/\/www.painresearch.utah.edu\/cancerpain\/ch15.html#ch15.html_1<\/a>"},{"key":"E00029","unstructured":"Schubert, M.M., Williams, B.E., Lloid, M.E., Donaldson, G., & Chapko, M.K. (2002). Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer<\/i>, 69<\/i>, 2469-2477."},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Shih, A., Miaskowski, C., Dodd, M.J., Stotts, N.A., & MacPhail, L. (2002). A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer. Oncology Nursing Forum<\/i>, 29<\/i>, 1063-1080.","DOI":"10.1188\/02.ONF.1063-1080"},{"key":"E00031","unstructured":"Sonis, S.T. (2004a). A biological approach to mucositis. Journal of Supportive Oncology<\/i>, 2<\/i>, 21-32."},{"key":"E00032","unstructured":"Sonis, S.T. (2004b). Oral mucositis in cancer therapy. Journal of Supportive Oncology<\/i>, 2<\/i>(Suppl. 3), 3-8."},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Sonis, S.T. (2004c). Pathobiology of mucositis. Seminars in Oncology Nursing<\/i>, 20<\/i>, 11-15.","DOI":"10.1053\/j.soncn.2003.10.003"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVeque, F.G., Liggett, W.H., Jr., Mulagha, M.T., et al. (1999). Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer<\/i>, 85<\/i>, 2103-2113.","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Sonis, S.T., Elting, L.S., Keefe, D., Peterson, D.E., Schubert, M., Hauer-Jensen, M., et al. (2004). Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer<\/i>, 100<\/i>(9, Suppl.), 1995-2025.","DOI":"10.1002\/cncr.20162"},{"key":"E00036","unstructured":"Sonis, S.T., & Fey, E.G. (2002). Oral complications of cancer therapy. Oncology<\/i>, 16<\/i>, 680-686."},{"key":"E00037","doi-asserted-by":"crossref","unstructured":"Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., et al. (2004). Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine<\/i>, 351<\/i>, 2590-2598.","DOI":"10.1056\/NEJMoa040125"},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Trotti, A., Bellm, L.A., Epstein, J.B., Frame, D., Fuchs, H.J., Gwede, C.K., et al. (2003). Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiotherapy and Oncology<\/i>, 66<\/i>, 253-262.","DOI":"10.1016\/S0167-8140(02)00404-8"},{"key":"E00039","unstructured":"Wilkes, G.M., & Ades, T.B. (2004). Consumers guide to cancer drugs<\/i> (2nd ed.). Sudbury, MA: Jones and Bartlett."},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Woo, S.B., Sonis, S.T., Monopoli, M.M., & Sonis, A.L. (1993). A longitudinal study of oralulcerative mucositis in bone marrow transplant recipients. Cancer<\/i>, 72<\/i>, 1612-1617.","DOI":"10.1002\/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q"},{"key":"E00041","unstructured":"World Health Organization. (1979). WHO handbook for reporting results of cancer treatment.<\/i> Geneva, Switzerland: Author."},{"key":"E00042","unstructured":"Zeischegg, P.M. (n.d.). Ask Dr. Z: Low level laser therapy (LLLT). Retrieved October 19, 2004, from http:\/\/65.110.92.148\/asp\/cp\/laser.asp<\/a>"},{"key":"E00043","doi-asserted-by":"crossref","unstructured":"Zerbe, M.B., Parkerson, S.G., Ortlieb, M.L., & Spitzer, T. (1992). Relationships between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nursing<\/i>, 15<\/i>, 196-205.","DOI":"10.1097\/00002820-199206000-00006"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/F05284072647451T.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:52:05Z","timestamp":1763754725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/9\/5\/current-trends-managing-oral-mucositis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10,1]]}},"alternative-id":["F05284072647451T"],"URL":"https:\/\/doi.org\/10.1188\/05.cjon.584-592","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}